Edition:
United Kingdom

Eris Lifesciences Ltd (ERIS.NS)

ERIS.NS on National Stock Exchange of India

447.20INR
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
Rs447.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,432
52-wk High
Rs786.00
52-wk Low
Rs440.00

Latest Key Developments (Source: Significant Developments)

Eris Lifesciences Approves Buyback Of Shares Worth Up To 1 Bln Rupees
Wednesday, 3 Jul 2019 

July 3 (Reuters) - Eris Lifesciences Ltd ::SAYS APPROVED BUYBACK PROPOSAL OF SHARES WORTH UP TO 1 BILLION RUPEES.  Full Article

Eris Lifesciences To Consider Proposal Of Buyback Of Fully Paid-Up Equity Shares
Monday, 24 Jun 2019 

June 24 (Reuters) - Eris Lifesciences Ltd ::SAYS TO CONSIDER A PROPOSAL OF BUYBACK OF FULLY PAID-UP EQUITY SHARES.  Full Article

India's Eris Lifesciences March Qtr Consol Net Profit Falls
Tuesday, 21 May 2019 

May 21 (Reuters) - Eris Lifesciences Ltd ::MARCH QUARTER CONSOL NET PROFIT 540.9 MILLION RUPEES VERSUS PROFIT 557.9 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 2.15 BILLION RUPEES VERSUS 2.12 BILLION RUPEES YEAR AGO.  Full Article

Eris Lifesciences Executes Agreement To Raise Stake In Unit Kinedex Healthcare By 6.71 Pct
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Eris Lifesciences Ltd ::CO EXECUTED AGREEMENT WITH FOUNDER AND PROMOTER OF UNIT KINEDEX HEALTHCARE TO RAISE STAKE IN KINDEX BY 6.71 PERCENT TO 82.19 PERCENT.  Full Article

India's Eris Lifesciences June-Qtr Consol Net Profit Rises
Thursday, 9 Aug 2018 

Aug 9 (Reuters) - Eris Lifesciences Ltd ::JUNE QUARTER CONSOL NET PROFIT 712.5 MILLION RUPEES VERSUS 708.4 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 2.51 BILLION RUPEES VERSUS 1.85 BILLION RUPEES YEAR AGO.  Full Article

Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Eris Lifesciences Ltd ::SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED.  Full Article